Biomas

Tellurium-based integrin inhibitors for range of indications

placeJerusalem, Jerusalem District, Israel calendar_todayFounded 2000 groups34 employees language biomas-pharma.com

Innovation

22 patent families (7 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace dormant. Cited 1,027 times.

YearFilings
20123
20131
20145
20155
20163
20174
20182

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon